Human placenta releases extracellular vesicles carrying corticotrophin releasing hormone mRNA into the maternal blood

Nilanjana Paul,Kaushik Maiti,Zakia Sultana,Joshua J. Fisher,Huiming Zhang,Nicole Cole,Terry Morgan,Roger Smith
DOI: https://doi.org/10.1016/j.placenta.2024.01.004
IF: 3.287
2024-01-06
Placenta
Abstract:The human placenta releases diverse extracellular vesicles (EVs), including microvesicles (100–1000nm) and exosomes (30–150nm), into the maternal blood for feto-maternal communication. Exosomes and microvesicles contribute to normal pregnancy physiology and major pregnancy pathologies. Besides, differences in miRNA expressions and protein content in placental exosomes have been reported in complicated pregnancies. During human pregnancy, Corticotropin-Releasing Hormone (CRH) is produced and released by the placenta into the maternal blood. CRH is involved in regulating the gestational length and initiation of labour. Like CRH peptide, CRH mRNA levels in the maternal plasma rise with gestation. In addition, high levels of CRH mRNA are reported to be associated with preeclamptic and preterm pregnancies. However, the underlying mechanism of placental CRH mRNA secretion remains elucidated. We hypothesise that the placenta releases CRH mRNA packaged within extracellular vesicles (EVs) into the maternal blood. In this study, placental EVs (microvesicles and exosomes) were isolated from human term healthy placentas via villus washes and from explant culture media by differential centrifugation and purified by density gradient ultracentrifugation using a continuous sucrose gradient (0.25–2.5M). Western blotting using placenta- and exosome-specific markers and electron microscopy confirmed exosomes and microvesicles in the placental wash and explant samples. Real-time quantitative RT-PCR data detected CRH mRNA in placenta-derived EVs from placental washes and explants. We also sorted placenta-secreted EVs in the maternal plasma samples (≥37 weeks) by high-resolution flow cytometry using fluorescent-labelled PLAP antibody. CRH mRNA was demonstrated in placental EVs obtained from maternal blood plasma. Therefore, our study showed that human placental EVs carry CRH mRNA into the maternal blood. This study also implies that detecting CRH mRNA in placental EVs in the maternal plasma could be a potential means of monitoring pregnancy.
obstetrics & gynecology,reproductive biology,developmental biology
What problem does this paper attempt to address?